{"altmetric_id":3267888,"counts":{"readers":{"mendeley":10,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:768604"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4f63cf058f610002f57","authors":["Antonio H Madrid","Javier Ortega","Jose G Rebollo","Juan G Manzano","Javier G Segovia","Andr\u00e9s S\u00e1nchez","Gonzalo Pe\u00f1a","Concepci\u00f3n Moro"],"doi":"10.1016\/s0735-1097(00)01155-4","endpage":"559","first_seen_on":"2015-02-03T15:34:08+00:00","issns":["07351097"],"issue":"2","journal":"Journal of the American College of Cardiology (JACC)","last_mentioned_on":1270413898,"links":["http:\/\/dx.doi.org\/10.1016\/S0735-1097(00)01155-4"],"pubdate":"2001-02-01T00:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"554","title":"Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study","type":"article","volume":"37","mendeley_url":"http:\/\/www.mendeley.com\/research\/lack-efficacy-atenolol-prevention-neurally-mediated-syncope-highly-symptomatic-population-prospectiv"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3629728,"mean":4.9326084606411,"rank":816310,"this_scored_higher_than_pct":63,"this_scored_higher_than":2290693,"rank_type":"exact","sample_size":3629728,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":94324,"mean":8.0753894172155,"rank":24449,"this_scored_higher_than_pct":72,"this_scored_higher_than":68784,"rank_type":"exact","sample_size":94324,"percentile":72},"this_journal":{"total_number_of_other_articles":2523,"mean":5.4726225218081,"rank":675,"this_scored_higher_than_pct":59,"this_scored_higher_than":1505,"rank_type":"exact","sample_size":2523,"percentile":59},"similar_age_this_journal_3m":{"total_number_of_other_articles":80,"mean":7.9686329113924,"rank":25,"this_scored_higher_than_pct":68,"this_scored_higher_than":55,"rank_type":"exact","sample_size":80,"percentile":68}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":5,"Researcher":1,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Student  > Master":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":10}}},"geo":{"mendeley":{"US":1,"MY":1}}},"posts":{"wikipedia":[{"title":"Vasovagal response","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=353968978#altmetric_citation_2","license":"public","citation_ids":[3267888,3267892],"posted_on":"2010-04-04T20:44:58+00:00","summary":"A vasovagal episode or vasovagal response or vasovagal attack (also called neurocardiogenic syncope) is a malaise mediated by the vagus nerve.","page_url":"http:\/\/en.wikipedia.org\/?curid=768604","wiki_lang":"en","author":{"name":"Davidruben","url":"http:\/\/en.wikipedia.org\/wiki\/User:Davidruben"}}]}}